Mode
Text Size
Log in / Sign up
N/A N=9 Randomized Single-blind

Influence of a Monopoly Game on Subtle Behaviors

Obesity · Eating Behavior

Enrolled (actual)
9
Serious AEs
0.0%
Results posted
Aug 2016
Primary outcome: Primary: Calories Consumed Following the Experimental Manipulation — 647.5; 520.9 kcal

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Low Social Status (Behavioral); High Social Status (Behavioral)
Age
Adult · 19+ yrs
Sex
All
Sponsor
University of Colorado, Denver
Primary completion
Dec 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Calories Consumed Following the Experimental Manipulation
647.5; 520.9
PRIMARY
The Macronutrient Composition of Foods Consumed
22.4; 17.0; 89.3; 75.4; 35.4; 30.9
PRIMARY
Percent of Calories Consumed Following the Experimental Manipulation
30.5; 27.9; 54.6; 58.0; 14.3; 12.3

Summary

This project will investigate the influence of experimentally manipulated perceived social standing on eating behavior and obesity risk.

Eligibility Criteria

Inclusion Criteria

  • Ages 19-25
  • Self-identified Hispanic ethnicity
  • Born in the United States
  • Body Mass Index (BMI) ≥18.5 and ≤30 kg/m2
  • A score on the MacArthur scale of subjective social status ≥3 and ≤8
  • No self-report of acute or chronic disease (heart disease, diabetes, gastrointestinal disorders in particular)
  • No plans for extended travel (>1 week) within the next 2 months
  • No current tobacco use
  • Capable and willing to give informed consent, understand inclusion criteria, and accept the randomized assignment

Exclusion Criteria

  • Never played monopoly before
  • Not born in the United States
  • Strict dietary restrictions (vegan, vegetarian, gluten-free, dairy-free/lactose intolerant, nut-allergies)
  • Participation in any weight reduction program, weight-loss diet, or other special diet within the previous 3 months
  • Weight loss or gain of ≥10 pounds in the past 6 months for any reason except post-partum weight loss
  • Currently taking medication that suppresses or stimulates appetite
  • Current smoker or quit smoking less than 6 months prior
  • Any major disease, including:
  • Active cancer or cancer requiring treatment in the past 2 years (except nonmelanoma skin cancer).
  • Active or chronic infections, including self-reported HIV positivity and active tuberculosis.
  • Diagnosis of cardiovascular disease
  • Gastrointestinal disease, including inflammatory bowel disease that has required treatment in the past year, celiac disease, recent of significant abdominal surgery
  • Active renal disease
  • Lung disease such as chronic obstructive airway disease requiring use of oxygen
  • Diagnosis of diabetes (type 1 or type 2)
  • Uncontrolled psychiatric disease (such as schizophrenia and bipolar disorder) that, in the opinion of the investigators, would impede conduct of the trial or completion of procedures
  • A score on the Brief Symptom Inventory (BSI) (Derogatis & Melisaratos, 1983) that exceeds the 90th percentile
  • History of or current eating disorders, or an Eating Attitudes Test (EAT-26) score >20.
  • Conditions or behaviors likely to effect the conduct of the trial: unable or unwilling to give informed consent; unable to communicate with the pertinent clinic staff; another household member is a participant or staff member in the trial; unwilling to accept social status assignment by randomization; current or anticipated participation in another intervention research project that would interfere with the intervention offered in the trial; likely to move away from participating university before visits are completed; unable to walk 0.25 mile in 10 minutes.
  • Currently taking antidepressant, steroid, or thyroid medication, unless dosage has been stable for at least 6 months.
  • A recent or ongoing problem with drug abuse or addiction.
  • Excessive alcohol intake, either acute or chronic, defined as any one of the following: 1) average consumption of 3 or more alcohol containing beverages daily; 2) consumption of 7 or more alcoholic beverages within a 24-hr period in the past 12 months; or 3) other evidence available to clinic staff.
  • Not willing to be randomized to any of the two experimental conditions.
  • Pregnancy and childbearing: currently pregnant or less than 3 months post-partum; currently nursing or within 6 weeks of having completed nursing; pregnancy anticipated during study; unwilling to report possible or confirmed pregnancies promptly during the course of the trial; unwilling to take adequate contraceptive measures if potentially fertile.
  • Any other conditions which, in opinion of the investigators, would adversely affect the conduct of the trial.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02470949). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search